Rowland Neil E, Farnbauch Laura J, Robertson Kimberly L
Department of Psychology, University of Florida, P.O. Box 112250, Gainesville, FL 32611-2250, USA.
Psychopharmacology (Berl). 2003 May;167(2):174-9. doi: 10.1007/s00213-003-1394-1. Epub 2003 Mar 25.
The brain regions and receptor subtypes involved in water intake following central cholinergic stimulation have been incompletely characterized.
To examine whether drinking and brain Fos-immunoreactivity (ir) induced in rats by central administration of bethanecol is reversed by either the preferential M1 antagonist pirenzepine, the M3 antagonist 4-DAMP, or their combination.
Male Sprague-Dawley rats were surgically implanted with cerebroventricular cannulae. The muscarinic agonist, bethanecol was used as the dipsogenic agent. Either nonselective (atropine) or selective muscarinic receptor antagonists were injected together with bethanecol to determine blockade of drinking. In parallel studies, Fos-ir was assessed in discrete brain regions.
Bethanecol-induced drinking was completely blocked by atropine or by a combination of pirenzepine and 4-DAMP; these latter antagonists alone produced sub-total inhibition of drinking. In contrast, water intake induced by angiotensin II was unaffected by combination of pirenzepine and 4-DAMP. Fos-ir was induced by bethanecol in many brain regions previously implicated in body fluid regulation, including subfornical organ and the magnocellular supraoptic and paraventricular hypothalamic nuclei. Induced Fos-ir was substantially but not completely prevented by co-injection of either pirenzepine or 4-DAMP, but their combination did not seem markedly more effective than either alone.
Drinking induced by brain muscarinic receptor stimulation seems to proceed by a combination of M1 and M3 receptor subtypes. Drinking induced by angiotensin II occurs independently of this mechanism. Fos-ir induced in fluid-related brain regions by bethanecol either uses additional receptor type(s) or is less easily blocked than drinking behavior.
中枢胆碱能刺激后参与水摄入的脑区和受体亚型尚未完全明确。
研究中枢给予氨甲酰甲胆碱诱导大鼠饮水及脑Fos免疫反应性(ir)是否可被选择性M1拮抗剂哌仑西平、M3拮抗剂4-二甲基氨基吡啶(4-DAMP)或二者联合用药逆转。
雄性Sprague-Dawley大鼠手术植入脑室套管。毒蕈碱激动剂氨甲酰甲胆碱用作致渴剂。非选择性(阿托品)或选择性毒蕈碱受体拮抗剂与氨甲酰甲胆碱一起注射以确定对饮水的阻断作用。在平行研究中,评估离散脑区的Fos-ir。
阿托品或哌仑西平与4-DAMP联合用药可完全阻断氨甲酰甲胆碱诱导的饮水;单独使用后两种拮抗剂只能部分抑制饮水。相比之下,血管紧张素II诱导的水摄入不受哌仑西平与4-DAMP联合用药的影响。氨甲酰甲胆碱在许多先前涉及体液调节的脑区诱导Fos-ir,包括穹窿下器官以及下丘脑视上核和室旁核的大细胞。预先注射哌仑西平或4-DAMP可显著但不能完全阻止诱导的Fos-ir,但其联合用药似乎并不比单独用药明显更有效。
脑毒蕈碱受体刺激诱导的饮水似乎是由M1和M3受体亚型共同介导。血管紧张素II诱导的饮水独立于该机制发生。氨甲酰甲胆碱在与体液相关脑区诱导的Fos-ir要么涉及其他受体类型,要么比饮水行为更难被阻断。